| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 294.92B | 338.38B | 343.07B | 344.53B | 335.22B |
| Gross Profit | 103.45B | 115.18B | 122.44B | 134.47B | 110.76B |
| EBITDA | 105.41B | 111.23B | 108.98B | 121.03B | 95.95B |
| Net Income | 52.85B | 58.67B | 59.69B | 69.65B | 50.08B |
Balance Sheet | |||||
| Total Assets | 627.76B | 658.07B | 630.13B | 621.70B | 607.05B |
| Cash, Cash Equivalents and Short-Term Investments | 96.77B | 159.72B | 150.28B | 170.50B | 162.89B |
| Total Debt | 29.65B | 31.00B | 36.87B | 56.94B | 65.41B |
| Total Liabilities | 146.31B | 154.12B | 151.76B | 162.46B | 161.38B |
| Stockholders Equity | 409.11B | 426.87B | 408.69B | 393.85B | 376.88B |
Cash Flow | |||||
| Free Cash Flow | 26.66B | 56.32B | 52.60B | 81.05B | 70.71B |
| Operating Cash Flow | 75.06B | 93.35B | 89.69B | 109.73B | 94.58B |
| Investing Cash Flow | -21.79B | -85.36B | -36.97B | -56.59B | -6.84B |
| Financing Cash Flow | -96.24B | -51.17B | -76.13B | -78.73B | -43.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.79B | 11.60 | 10.90% | 9.92% | -2.79% | -39.45% | |
74 Outperform | HK$1.14T | 13.10 | 13.43% | 8.97% | -13.87% | -15.41% | |
72 Outperform | HK$10.73B | -9.03 | 6.97% | ― | -20.50% | -64.45% | |
71 Outperform | HK$14.25B | 23.58 | 3.92% | 9.28% | -5.78% | -29.52% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$194.71B | 9.73 | ― | 8.02% | 0.80% | -35.81% | |
62 Neutral | HK$250.27B | 8.39 | 10.99% | 4.59% | -3.42% | -18.73% |